Two Different Doses of Tranexamic Acid for reduction of Perioperative Blood Loss in Cesarean Section: a randomized controlled study

faculty of medicine suez canal university0 个研究点目标入组 134 人开始时间: 2022年8月5日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•1)Age from 18- 45 years.
•2)Patients are ASA I (American Society of Anesthesiology physical status Grade I) = (normal healthy patients) or ASA II (American Society of Anesthesiologists physical status Grade II) = (patients with mild systemic disease and no functional limitations).
•3)term with singleton uncomplicated pregnancies.
•4)Body mass index of at most 40 kg/m2.

•1)Parturient with peri-partum disorders as DM, HTN, cardiac diseases, Sickle cell disease or bleeding disorders History of venous (deep vein thrombosis and/or pulmonary embolism) or arterial (angina pectoris, myocardial infarction, stroke) thrombosis.
•2)Known case of coagulation disorders.
•3)Severe anemia.
•4)Allergy to TXA.
•5)Severe medical and surgical complications involving the heart, liver, kidney, brain, and blood disorder.
•6)Abnormal placenta such as placenta previa and placental abruption.
•7)Pregnancy related complication like severe preeclampsia,
•8)Pregnancy with <37 weeks gestational age.
•9)Woman on anticoagulant therapy during the week
•10)Refusal to participate in the study

发起方